Skip to:

Epidemiology

Paul Dluzniewski

Paul Dluzniewski is currently a Director in the Center for Observational Research at Amgen. As product area lead for the cardiovascular-metabolic group, his work is focused on therapies used to treat patients at elevated risk of cardiovascular disease. He leads evidence generation efforts by conducting epidemiologic research to inform the benefit-risk profile of Amgen’s therapies and highlight the clinical value of both marketed and pipeline products.

Matthew J. Mimiaga

Matthew J. Mimiaga is tenured Professor of Epidemiology at UCLA and Senior Research Scientist at The Fenway Institute, Fenway Health. He is also Adjunct Professor of Epidemiology and Behavioral & Social Sciences at Brown University.

Joann G. Elmore

Dr. Joann G. Elmore is a professor of health policy and management at the UCLA Fielding School of Public Health and of medicine in the Division of General Internal Medicine, in the Department of Medicine at the David Geffen School of Medicine at UCLA. She also serves as Director of the UCLA National Clinician Scholars Program. She is a national leader in academic general internal medicine and has a distinguished career as an investigator, mentor, administrator and educator. 

Jennifer Wagman

Dr. Wagman earned her PhD in Reproductive, Perinatal and Women’s Health and her Master’s degree of Health Science in International Health from the Johns Hopkins Bloomberg School of Public Health; and a Bioethics and Health Policy Certificate from the Johns Hopkins Berman Institute of Bioethics. Her postdoctoral training, completed at the UC San Diego School of Medicine, was in alcohol and substance use, HIV and related infections. Since 2000, Dr.

Marissa Seamans

Marissa Seamans, PhD, MSPH, is an Assistant Professor in the Department of Epidemiology. Dr. Seamans’ research focuses on the intersection of social epidemiology and pharmacoepidemiology to address substance use and mental health. Her work explores the use of large healthcare databases to examine prescription drug use in families and the effectiveness of treatments for mental health and substance use disorders. Methodologically, Dr.

Dvora Joseph Davey

Dr. Joseph Davey's research focuses on how best to prevent and treat HIV and other sexually transmitted infections in peri-conception, pregnant women and couples, as well as other vulnerable populations. She has expertise in study design and use of epidemiological methods to inform interventions aimed at reducing the burden of HIV and related diseases on women, children, and families.

Steven Teutsch

Steven M. Teutsch, MD, MPH is an adjunct professor at the UCLA Fielding School of Public Health; Senior Fellow at the Public Health Institute; and Senior Fellow at the Leonard D. Schaeffer Center for Health Policy and Economics at the  University of Southern California.

Roch A. Nianogo

Roch Nianogo is an Assistant Professor in the Department of Epidemiology at the UCLA Fielding School of Public Health. He is a physician and scientist of preventive medicine and epidemiologist. Dr. Nianogo’s research strives to help reduce the burden of preventable chronic diseases, promote the health and wellbeing of patients and populations, especially those most vulnerable, and assist clinical, public health and policy decision-making. To this end, Dr. Nianogo has developed research interests that are both methodological and substantive in nature.

Amy Wohl

Dr. Amy Wohl is an Epidemiologist who has worked for the Los Angeles County Department of Public Health (DPH)/Health Services (DHS) for 26 years. She currently oversees the Program Evaluation Unit in the Los Angeles County Health Agency and DHS Office of Planning and Data Analytics where she conducts research and evaluation on health outcomes and service utilization for high-need Medi-Cal clients and DHS patients.

Alexandra M. Binder

My research has focused on the potential of epigenetic epidemiology to elucidate the pathway by which adult disease susceptibility is influenced by environmental stimuli during critical periods of plasticity in fetal development. To explore multiple facets of this regulatory network, I have worked to develop expertise in the preprocessing and analysis of sequencing and microarray approaches to interrogate genetic variation, chromatin modifications, mRNA expression, and DNA methylation. In association with the post-doctoral molecular biologists in Dr.

Pages

Subscribe to RSS - Epidemiology